@article{KannKunzHansenetal.2020, author = {Kann, Simone and Kunz, Meik and Hansen, Jessica and Sievertsen, J{\"u}rgen and Crespo, Jose J. and Loperena, Aristides and Arriens, Sandra and Dandekar, Thomas}, title = {Chagas disease: detection of Trypanosoma cruzi by a new, high-specific real time PCR}, series = {Journal of Clinical Medicine}, volume = {9}, journal = {Journal of Clinical Medicine}, number = {5}, issn = {2077-0383}, doi = {10.3390/jcm9051517}, url = {http://nbn-resolving.de/urn:nbn:de:bvb:20-opus-205746}, year = {2020}, abstract = {Background: Chagas disease (CD) is a major burden in Latin America, expanding also to non-endemic countries. A gold standard to detect the CD causing pathogen Trypanosoma cruzi is currently not available. Existing real time polymerase chain reactions (RT-PCRs) lack sensitivity and/or specificity. We present a new, highly specific RT-PCR for the diagnosis and monitoring of CD. Material and Methods: We analyzed 352 serum samples from Indigenous people living in high endemic CD areas of Colombia using three leading RT-PCRs (k-DNA-, TCZ-, 18S rRNA-PCR), the newly developed one (NDO-PCR), a Rapid Test/enzyme-linked immuno sorbent assay (ELISA), and immunofluorescence. Eighty-seven PCR-products were verified by sequence analysis after plasmid vector preparation. Results: The NDO-PCR showed the highest sensitivity (92.3\%), specificity (100\%), and accuracy (94.3\%) for T. cruzi detection in the 87 sequenced samples. Sensitivities and specificities of the kDNA-PCR were 89.2\%/22.7\%, 20.5\%/100\% for TCZ-PCR, and 1.5\%/100\% for the 18S rRNA-PCR. The kDNA-PCR revealed a 77.3\% false positive rate, mostly due to cross-reactions with T. rangeli (NDO-PCR 0\%). TCZ- and 18S rRNA-PCR showed a false negative rate of 79.5\% and 98.5\% (NDO-PCR 7.7\%), respectively. Conclusions: The NDO-PCR demonstrated the highest specificity, sensitivity, and accuracy compared to leading PCRs. Together with serologic tests, it can be considered as a reliable tool for CD detection and can improve CD management significantly.}, language = {en} } @article{KannBruennertHansenetal.2020, author = {Kann, Simone and Bruennert, Daniela and Hansen, Jessica and Concha Mendoza, Gustavo Andr{\´e}s and Crespo Gonzalez, Jos{\´e} Jos{\´e} and Armenta Quintero, Cielo Leonor and Hanke, Miriam and Hagen, Ralf Matthias and Backhaus, Joy and Frickmann, Hagen}, title = {High prevalence of intestinal pathogens in Indigenous in Colombia}, series = {Journal of Clinical Medicine}, volume = {9}, journal = {Journal of Clinical Medicine}, number = {9}, issn = {2077-0383}, doi = {10.3390/jcm9092786}, url = {http://nbn-resolving.de/urn:nbn:de:bvb:20-opus-211289}, year = {2020}, abstract = {Background: Intestinal infections remain a major public health burden in developing countries. Due to social, ecological, environmental, and cultural conditions, Indigenous peoples in Colombia are at particularly high risk. Materials: 137 stool samples were analyzed by microscopy and real-time-Polymerase Chain Reaction (RT-PCR), targeting protozoan parasites (Giardia intestinalis, Entamoeba histolytica, Cryptosporidium spp., and Cyclospora cayetanensis), bacteria (Campylobacter jejuni, Salmonella spp., Shigella ssp./enteroinvasive E. coli (EIEC), Yersinia spp., enterohemorrhagic E. coli (EHEC), enteropathogenic E. coli (EPEC), enterotoxin-producing E. coli (ETEC), enteroaggregative E. coli (EAEC), and Tropheryma whipplei), and helminths (Necator americanus, Strongyloides stercoralis, Ascaris lumbricoides, Ancylostoma spp., Trichuris. trichiura, Taenia spp., Hymenolepis nana, Enterobius vermicularis, and Schistosoma spp.). Microscopy found additional cases of helminth infections. Results: At least one pathogen was detected in 93\% of the samples. The overall results revealed protozoa in 79\%, helminths in 69\%, and bacteria in 41\%. G. intestinalis (48\%), Necator/hookworm (27\%), and EAEC (68\%) were the most common in each group. Noteworthy, T. whipplei was positive in 7\% and T. trichirua in 23\% of the samples. A significant association of one infection promoting the other was determined for G. intestinalis and C. jejuni, helminth infections, and EIEC. Conclusions: The results illustrate the high burden of gastrointestinal pathogens among Indigenous peoples compared to other developing countries. Countermeasures are urgently required.}, language = {en} } @article{KannBlessmannWinkelmannetal.2021, author = {Kann, Simone and Blessmann, Joerg and Winkelmann, Yvonne and Hansen, Jessica and Maya Amaya, Leonardo J. and Rivera Salcedo, Gadith E. and Halas, Hussein El and Schmidt-Chanasit, Jonas and Keoviengkhone, Latdamone and Sopraseuth, Vatsana and Deschermeier, Christina and Mika, Angela}, title = {Dengue virus detection in Lao PDR and Colombia: Comparative evaluation of PCR tests}, series = {Tropical Medicine \& International Health}, volume = {26}, journal = {Tropical Medicine \& International Health}, number = {10}, doi = {10.1111/tmi.13670}, url = {http://nbn-resolving.de/urn:nbn:de:bvb:20-opus-262703}, pages = {1296 -- 1302}, year = {2021}, abstract = {Objectives Dengue virus (DENV) detection by polymerase chain reaction (PCR) facilitates diagnosis of dengue fever, which is the most frequent arboviral disease globally. Two studies were performed in countries with high dengue incidence, to assess the diagnostic performance of different PCR techniques. Methods/Results Two hundred and seventy-nine acute phase blood samples from febrile patients were analyzed for DENV by the RealStar Dengue RT-PCR kit (Altona Diagnostics) as gold standard in comparison with the Tropical Fever Core multiplex PCR (Fast Track Diagnostics). In total, 102 samples collected in Savannakhet Province (Lao PDR, Southeast Asia) in 2013 and 35 samples from Valledupar (Colombia, South America) tested positive for DENV by RealStar RT-PCR. In comparison, the Tropical Fever Core multiplex PCR detected 65.0\% (65/102) and 68.6\% (24/35) of these samples as positive for DENV in Savannakhet and Valledupar, respectively. Diagnostic sensitivity of the multiplex PCR strongly correlated with viral load. A subset of DENV PCR-confirmed samples was additionally tested by BNITM in house Dengue Type RT-PCR in comparison with two commercial test kits (RealStar Dengue Type RT-PCR [Altona Diagnostics], Dengue differentiation PCR [Fast Track Diagnostics]). The leading dengue serotype in Savannakhet was DENV-3 (58\% [29/50]), while DENV-1 (53.8\% [14/26]) was the predominant serotype found in samples collected in Valledupar by BNITM-type PCR. However, three DENV serotypes were circulating in Valledupar and in Savannakhet. In 2015, additional studies found predominantly DENV-4 (71\% [12/17]) in Savannakhet. Conclusions Both studies emphasized that routine diagnostics in both regions will benefit from an expanded use of highly sensitive pan-dengue PCRs.}, language = {en} } @article{EmmerichMurawskiEhmenetal.2021, author = {Emmerich, Petra and Murawski, Carolin and Ehmen, Christa and von Possel, Ronald and Pekarek, Neele and Oestereich, Lisa and Duraffour, Sophie and Pahlmann, Meike and Struck, Nicole and Eibach, Daniel and Krumkamp, Ralf and Amuasi, John and Maiga-Ascofar{\´e}, Oumou and Rakotozandrindrainy, Raphael and Asogun, Danny and Ighodalo, Yemisi and Kann, Simone and May, J{\"u}rgen and Tannich, Egbert and Deschermeier, Christina}, title = {Limited specificity of commercially available SARS-CoV-2 IgG ELISAs in serum samples of African origin}, series = {Tropical Medicine \& International Health}, volume = {26}, journal = {Tropical Medicine \& International Health}, number = {6}, doi = {10.1111/tmi.13569}, url = {http://nbn-resolving.de/urn:nbn:de:bvb:20-opus-239899}, pages = {621 -- 631}, year = {2021}, abstract = {Objectives Specific serological tests are mandatory for reliable SARS-CoV-2 diagnostics and seroprevalence studies. Here, we assess the specificities of four commercially available SARS-CoV-2 IgG ELISAs in serum/plasma panels originating from Africa, South America, and Europe. Methods 882 serum/plasma samples collected from symptom-free donors before the COVID-19 pandemic in three African countries (Ghana, Madagascar, Nigeria), Colombia, and Germany were analysed with three nucleocapsid-based ELISAs (Euroimmun Anti-SARS-CoV-2-NCP IgG, EDI™ Novel Coronavirus COVID-19 IgG, Mikrogen recomWell SARS-CoV-2 IgG), one spike/S1-based ELISA (Euroimmun Anti-SARS-CoV-2 IgG), and in-house common cold CoV ELISAs. Results High specificity was confirmed for all SARS-CoV-2 IgG ELISAs for Madagascan (93.4-99.4\%), Colombian (97.8-100.0\%), and German (95.9-100.0\%) samples. In contrast, specificity was much lower for the Ghanaian and Nigerian serum panels (Ghana: NCP-based assays 77.7-89.7\%, spike/S1-based assay 94.3\%; Nigeria: NCP-based assays 39.3-82.7\%, spike/S1-based assay 90.7\%). 15 of 600 African sera were concordantly classified as positive in both the NCP-based and the spike/S1-based Euroimmun ELISA, but did not inhibit spike/ACE2 binding in a surrogate virus neutralisation test. IgG antibodies elicited by previous infections with common cold CoVs were found in all sample panels, including those from Madagascar, Colombia, and Germany and thus do not inevitably hamper assay specificity. Nevertheless, high levels of IgG antibodies interacting with OC43 NCP were found in all 15 SARS-CoV-2 NCP/spike/S1 ELISA positive sera. Conclusions Depending on the chosen antigen and assay protocol, SARS-CoV-2 IgG ELISA specificity may be significantly reduced in certain populations probably due to interference of immune responses to endemic pathogens like other viruses or parasites.}, language = {en} } @article{BauerConchaMendozaKreienbrocketal.2022, author = {Bauer, Hannah and Concha Mendoza, Gustavo Andr{\´e}s and Kreienbrock, Lothar and Hartmann, Maria and Frickmann, Hagen and Kann, Simone}, title = {Prevalence of common diseases in Indigenous people in Colombia}, series = {Tropical Medicine and Infectious Disease}, volume = {7}, journal = {Tropical Medicine and Infectious Disease}, number = {6}, issn = {2414-6366}, doi = {10.3390/tropicalmed7060109}, url = {http://nbn-resolving.de/urn:nbn:de:bvb:20-opus-278953}, year = {2022}, abstract = {The Indigenous tribe called the Wiwa lives retracted in the Sierra Nevada de Santa Marta, Colombia. Little is known about their health status and whether the health care system in place covers their needs. In 2017 and 2018, a permanent physician was in charge for the Wiwa. Diseases and complaints were registered, ranked, and classified with the ICD-10 coding. Datasets from the Indigenous health care provider Dusakawi, collected from local health points and health brigades travelling sporadically into the fields for short visits, were compared. Furthermore, a list of provided medication was evaluated regarding the recorded needs. The most common complaints found were respiratory, infectious and parasitic, and digestive diseases. The top ten diagnoses collected in the health points and in the health brigade datasets were similar, although with a different ranking. The available medication showed a basic coverage only, with a critical lack of treatment for many severe, chronic, and life-threatening diseases. Most of the detected diseases in the Indigenous population are avoidable by an improvement in health care access, an expansion of the provided medication, and an increase in knowledge, hygiene, and life standards.}, language = {en} }